These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 6113584
21. [The risk of rehospitalisation during therapy with atypical and typical neuroleptics--a contribution to differential indication]. Müller P, Nerenz H, Schaefer E. Psychiatr Prax; 2002 Oct; 29(7):388-91. PubMed ID: 12378421 [Abstract] [Full Text] [Related]
23. Experience with depot neuroleptics in ambulatory practice. Fiolet J. Acta Psychiatr Belg; 1981 Oct; 81(2):182-8. PubMed ID: 6117188 [Abstract] [Full Text] [Related]
24. The long-term treatment of schizophrenia in the community. Rollin HR. Practitioner; 1982 Jul; 226(1369):1330-3. PubMed ID: 6125936 [No Abstract] [Full Text] [Related]
25. [Psychological aspects of depot treatment of schizophrenic syndromes]. Jacobsson L, Odling H. Lakartidningen; 1980 Oct 01; 77(40):3522-6. PubMed ID: 6109045 [No Abstract] [Full Text] [Related]
26. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia. Pecknold JC. J Psychiatry Neurosci; 1993 Mar 01; 18(2):82-4. PubMed ID: 8096393 [Abstract] [Full Text] [Related]
27. The attitude of patients towards antipsychotic depot treatment. Heres S, Schmitz FS, Leucht S, Pajonk FG. Int Clin Psychopharmacol; 2007 Sep 01; 22(5):275-82. PubMed ID: 17690596 [Abstract] [Full Text] [Related]
28. [Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)]. Rektor L, Blazek J. Cesk Psychiatr; 1980 Sep 01; 76(6):369-75. PubMed ID: 7471277 [No Abstract] [Full Text] [Related]
29. Impace of depot neuroleptics on psychiatry. Corbett L. Minn Med; 1979 Feb 01; 62(2):97-100. PubMed ID: 34788 [No Abstract] [Full Text] [Related]
30. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables. Stanković Z, Britvić D, Vuković O, Ille T. Psychiatr Danub; 2008 Mar 01; 20(1):42-52. PubMed ID: 18376330 [Abstract] [Full Text] [Related]
31. [Current questions on the use of neuroleptics in everyday practice]. Perényi A, Frecska E. Orv Hetil; 1984 Dec 02; 125(49):2985-8, 2991. PubMed ID: 6151164 [No Abstract] [Full Text] [Related]
34. [On the question of differences between therapeutic responses after particular neuroleptics in comparison to perphenazine in schizophrenics (author's transl)]. Náhunek K, Svestka J, Cesková E. Cesk Psychiatr; 1981 Feb 02; 77(1):25-30. PubMed ID: 6113897 [No Abstract] [Full Text] [Related]
35. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. Turner MS, Stewart DW. J Psychopharmacol; 2006 Nov 02; 20(6 Suppl):20-37. PubMed ID: 17046985 [Abstract] [Full Text] [Related]
36. The case for long-acting antipsychotic agents in the post-CATIE era. Nasrallah HA. Acta Psychiatr Scand; 2007 Apr 02; 115(4):260-7. PubMed ID: 17355516 [Abstract] [Full Text] [Related]
37. [Prolonged action neuroleptics and the relationship between physician, patient and family]. Boudef M. Sante Ment Que; 1995 Apr 02; 20(1):233-47. PubMed ID: 7578708 [No Abstract] [Full Text] [Related]
38. [Longterm therapy of schizophrenia]. Pajonk FG, Wobrock T, Falkai P. Fortschr Neurol Psychiatr; 2005 Mar 02; 73(3):161-74; quiz 175-7. PubMed ID: 15747226 [No Abstract] [Full Text] [Related]
39. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia. Johnson DA. J Clin Psychiatry; 1984 May 02; 45(5 Pt 2):13-21. PubMed ID: 6143743 [Abstract] [Full Text] [Related]